MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
Funding: Strategic Corporate Investment & Corporate Venture Capital (CVC)
Google Ventures (GV) - #4 Most Active Digital Health Strategic Corporate Investor (2014)
*Finance & Acquisition: Google Ventures (GV)
WatchList: Closing, Closed, Inactive, Liquidation, Dissolution or Out of Business
2025: The 2025 Biotech Graveyard
Velia Therapeutics
Parents
2025: The 2025 Biotech Graveyard
Architects: BioPharmaceuticals_Inflammation, Allergy & Autoimmune
Architects: Biotechnology_Genomics, Multiomics
Architects: Biotechnology_Proteomics
Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology
WatchList: Closing, Closed, Inactive, Liquidation, Dissolution or Out of Business
Children
2025: Velia Therapeutics winds down but stays loyal to 'therapeutic potential of microproteins'
Employees 43 (2025)
Founded 2021
San Diego, California
The company offers comprehensive genomic and proteomic data analysis, advanced bioinformatics, and customizable research tools
Velia’s co-founder Alan Saghatelian, Ph.D. (2025)